当前位置:首页 - 行情中心 - 启迪药业(000590) - 财务分析 - 现金流量表

启迪药业

(000590)

  

流通市值:26.55亿  总市值:26.56亿
流通股本:2.39亿   总股本:2.39亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金258,105,478.45173,900,130.4242,260,219.97425,064,352.77
  收到其他与经营活动有关的现金71,494,153.9569,750,067.9615,986,571.4634,903,187.77
  经营活动现金流入小计329,599,632.4243,650,198.3858,246,791.43459,967,540.54
  购买商品、接受劳务支付的现金112,486,788.0971,094,983.7134,785,343.82185,794,264.06
  支付给职工以及为职工支付的现金105,089,944.6477,030,515.1648,503,544135,073,622.56
  支付的各项税费35,904,790.9230,613,272.8511,076,497.6236,356,190.86
  支付其他与经营活动有关的现金42,986,380.8633,961,206.5517,672,384.8985,355,490.19
  经营活动现金流出小计296,467,904.51212,699,978.27112,037,770.33442,579,567.67
  经营活动产生的现金流量净额33,131,727.8930,950,220.11-53,790,978.917,387,972.87
二、投资活动产生的现金流量:
  收回投资收到的现金168,000,000135,000,00065,000,000260,000,000
  取得投资收益收到的现金355,929.69299,874.9161,696.82536,643.55
  处置固定资产、无形资产和其他长期资产收回的现金净额126,06922,00022,00014,160
  投资活动现金流入小计168,481,998.69135,321,874.965,183,696.82260,550,803.55
  购建固定资产、无形资产和其他长期资产支付的现金32,333,049.4527,300,778.758,025,04932,102,860.61
  投资支付的现金201,000,000135,000,00065,000,000260,000,000
  投资活动现金流出小计233,333,049.45162,300,778.7573,025,049292,102,860.61
  投资活动产生的现金流量净额-64,851,050.76-26,978,903.85-7,841,352.18-31,552,057.06
三、筹资活动产生的现金流量:
  吸收投资收到的现金---350,000
  其中:子公司吸收少数股东投资收到的现金---350,000
  取得借款收到的现金46,899,788.7742,830,821.0833,054,890.3638,111,890.92
  收到其他与筹资活动有关的现金5,000,0005,000,000--
  筹资活动现金流入小计51,899,788.7747,830,821.0833,054,890.3638,461,890.92
  偿还债务支付的现金35,000,0005,000,000-34,887,920
  分配股利、利润或偿付利息支付的现金2,848,669.911,781,417.39838,508.693,555,326.93
  其中:子公司支付给少数股东的股利、利润317,471.63--90,000
  支付其他与筹资活动有关的现金1,922,618.041,513,351.58233,706.663,329,557.72
  筹资活动现金流出小计39,771,287.958,294,768.971,072,215.3541,772,804.65
  筹资活动产生的现金流量净额12,128,500.8239,536,052.1131,982,675.01-3,310,913.73
五、现金及现金等价物净增加额-19,590,822.0543,507,368.37-29,649,656.07-17,474,997.92
  加:期初现金及现金等价物余额160,588,687.75160,588,687.75160,588,687.75178,063,685.67
  期末现金及现金等价物余额140,997,865.7204,096,056.12130,939,031.68160,588,687.75
补充资料:
  净利润--17,263,541.22--127,230,053.08
  资产减值准备-640.48-119,237,884.73
  固定资产和投资性房地产折旧-11,304,627.01-20,039,039.32
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-11,304,627.01-20,039,039.32
  无形资产摊销-3,293,234.28-6,286,584.32
  长期待摊费用摊销-807,362.4-888,050.24
  处置固定资产、无形资产和其他长期资产的损失--3,444,349.77--4,780.83
  固定资产报废损失-845.53-266,521.57
  公允价值变动损失---871,950.28
  财务费用-1,907,967.66-3,661,916.25
  投资损失--36,284.33--372,373.55
  递延所得税--3,787,940.55--4,856,348.81
  其中:递延所得税资产减少--3,553,823.96--4,566,069.39
    递延所得税负债增加--234,116.59--290,279.42
  存货的减少--762,918.77-5,129,522.21
  经营性应收项目的减少-55,866,115.02--4,291,009.21
  经营性应付项目的增加--11,814,123.51--32,028,291.43
  其他--6,537,613.08-26,901,757.6
  现金的期末余额-204,096,056.12-160,588,687.75
  减:现金的期初余额-160,588,687.75-178,063,685.67
  现金及现金等价物的净增加额-43,507,368.37--17,474,997.92
公告日期2025-10-302025-08-272025-04-282025-03-28
审计意见(境内)标准无保留意见
TOP↑